However, the AAO and the North American Neuro-Ophthalmology Society do not support this blanket recommendation
Total weight loss at plateau generally lands between 18 and 22 percent for the 15 mg maintenance dose
While early trial results suggest retatrutide may be even more effective than current weight-loss medications, some providers are irresponsibly offering it to patients based on the assumption that approval is inevitable
Research peptides are sold for investigational purposes only and are not approved for human therapeutic use
There are a few important things to consider
Balland E, Dam J, Langlet F, Caron E, Steculorum S, Messina A, et al